Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Board chair at ONC

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Apr 18, 2021 8:25pm

92 Views

Post# 33019869

RE:RE:RE:RE:RE:RE:RE:RE:Board chair at ONC

LT, was it you who tallied up the % ownership a while back or was that reality, palinc, scarlet, or someone else. It would be useful to dig that back out to see what that number was.

longterm56 wrote: This has been a very enlightening discussion thread. It is obvious that if any serious LARGE investor did a little research on the make-up of the BOD, they would quickly conclude that THTX was not prepared to handle such a potential in their pipeline and simply find another alternative ... since there are hundreds of options out there. We may have identified not only A problem, but THE problem!

Another result of this discussion ... I convinced a friend today to invest a bit more in THTX but I think I will have them postpone that purchase until we see an attempt to fix this problem (just like the large investors are probably doing).

I'm in!!

-LT

Wino115 wrote: " If the company is going to have important developments totally ignored, what chance do we shareholders have of success????"